https://ir.adaptinbio.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_e2082ac3f9b9e6552652333d30c273b8/adaptinbio/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.adaptinbio.com/news-events/press-releases/detail/10/adaptin-bio-shares-to-be-quoted-on-the-otcqb-under-ticker-symbol-aptn Mon, 06 Apr 26 10:00:00 -0400 https://ir.adaptinbio.com/news-events/press-releases/detail/10/adaptin-bio-shares-to-be-quoted-on-the-otcqb-under-ticker-symbol-aptn https://ir.adaptinbio.com/news-events/press-releases/detail/12/adaptin-bio-advances-novel-brain-cancer-treatment-candidate-towards-phase-1-glioblastoma-clinical-trial Wed, 21 Jan 26 08:00:00 -0500 https://ir.adaptinbio.com/news-events/press-releases/detail/12/adaptin-bio-advances-novel-brain-cancer-treatment-candidate-towards-phase-1-glioblastoma-clinical-trial https://ir.adaptinbio.com/news-events/press-releases/detail/11/adaptin-bio-to-present-at-the-2026-sequire-investor-summit-in-puerto-rico Thu, 15 Jan 26 08:00:00 -0500 https://ir.adaptinbio.com/news-events/press-releases/detail/11/adaptin-bio-to-present-at-the-2026-sequire-investor-summit-in-puerto-rico https://ir.adaptinbio.com/news-events/press-releases/detail/9/adaptin-bio-inc-a-lucius-partners-portfolio-company-completes-alternative-public-offering-apo-and-closes-7-7-million-private-placement Mon, 07 Apr 25 12:25:00 -0400 https://ir.adaptinbio.com/news-events/press-releases/detail/9/adaptin-bio-inc-a-lucius-partners-portfolio-company-completes-alternative-public-offering-apo-and-closes-7-7-million-private-placement https://ir.adaptinbio.com/news-events/press-releases/detail/5/adaptin-bio-announces-fda-clearance-of-ind-application-for-aptn-101-in-glioblastoma Wed, 04 Sep 24 08:00:00 -0400 https://ir.adaptinbio.com/news-events/press-releases/detail/5/adaptin-bio-announces-fda-clearance-of-ind-application-for-aptn-101-in-glioblastoma